Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Clinical trial NCT01719250 · COMPLETED

Trial details

NCT number: NCT01719250
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Refractory Mantle Cell Lymphoma Transformed Recurrent Non-Hodgkin Lymphoma

Start date: 2012-12-01
Primary completion: 2016-09-16
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.